SIRT1, as well as SIRT3, SIRT5 and SIRT6, have been shown to be downregulated in patients with NAFLD with subsequent upregulation of lipogenic genes, including SREBP-1, FASN and ACC [251]. Here, SREBF1 is linked to metabolic dysfunction-associated steatotic liver disease.